Zhang, Ze http://orcid.org/0000-0001-9854-5823
Butler, Rondi http://orcid.org/0000-0002-6474-8953
Koestler, Devin C. http://orcid.org/0000-0002-0598-0146
Bell-Glenn, Shelby
Warrier, Gayathri
Molinaro, Annette M. http://orcid.org/0000-0002-9854-7404
Christensen, Brock C. http://orcid.org/0000-0003-3022-426X
Wiencke, John K. http://orcid.org/0000-0001-7101-6489
Kelsey, Karl T. http://orcid.org/0000-0002-2302-1600
Salas, Lucas A. http://orcid.org/0000-0002-2279-4097
Funding for this research was provided by:
NIH (R01CA216265, R01CA253976, R01 CA207360, R01 CA207360, R01CA216265, R01 CA207360, R01CA253976)
Department of Defense (W81XWH-20-1-0778, W81XWH-20-1-0778)
NIGMS (P20GM104416/8299, P20 GM130423, P20 GM130423, P20GM104416/8299)
American Association for Cancer Research (18‐90‐52‐MICH, 18‐90‐52‐MICH)
NCI (P30 CA168524, P30 CA168524)
Magnin Newman Endowment for Neuro-oncology
Article History
Received: 23 May 2022
Accepted: 5 December 2022
First Online: 15 December 2022
Declarations
:
: The relevant research is approved by Brown University IRB.
: The final version of the manuscript has been reviewed and approved by all authors.
: Drs. Kelsey and Wiencke are founders of Cellintec, which had no role in this research.